The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production
Nutrients · 16.10.2023 · 15 (20) · 4391
DOI: 10.3390/nu15204391 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 16.10.2023. Verfasst von Songhyun Ju und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Schizophrenia. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Schizophrenia, a severe mental illness affecting about 1% of the population, manifests during young adulthood, leading to abnormal mental function and behavior. Its multifactorial etiology involves genetic factors, experiences of adversity, infection, and gene–environment interactions. Emerging research indicates that maternal infection or stress during pregnancy may also increase schizophrenia risk in offspring. Recent research on the gut–brain axis highlights the gut microbiome’s potential influence on central nervous system (CNS) function and mental health, including schizophrenia. The gut microbiota, located in the digestive system, has a significant role to play in human physiology, affecting immune system development, vitamin synthesis, and protection against pathogenic bacteria. Disruptions to the gut microbiota, caused by diet, medication use, environmental pollutants, and stress, may lead to imbalances with far-reaching effects on CNS function and mental health. Of interest are short-chain fatty acids (SCFAs), metabolic byproducts produced by gut microbes during fermentation. SCFAs can cross the blood–brain barrier, influencing CNS activity, including microglia and cytokine modulation. The dysregulation of neurotransmitters produced by gut microbes may contribute to CNS disorders, including schizophrenia. This review explores the potential relationship between SCFAs, the gut microbiome, and schizophrenia. Our aim is to deepen the understanding of the gut–brain axis in schizophrenia and to elucidate its implications for future research and therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Biomedical Science Institute, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Insug Kang
Förderung
- National Research Foundation of Korea
Zitieren
APA
Ju, S., Shin, Y., Han, S., Kwon, J., Choi, T. G., Kang, I., & Kim, S. S. (2023). The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production. Nutrients, 15(20), 4391. https://doi.org/10.3390/nu15204391
Vancouver
Ju S, Shin Y, Han S, Kwon J, Choi TG, Kang I, et al. The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production. Nutrients. 2023;15(20):4391. doi:10.3390/nu15204391
BibTeX
@article{Ju2023,
author = {Ju, Songhyun and Shin, Yoonhwa and Han, Sunhee and Kwon, Juhui and Choi, Tae Gyu and Kang, Insug and Kim, Sung Soo},
title = {The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {20},
pages = {4391},
doi = {10.3390/nu15204391}
}
EUVIMED